X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8185) 8185
Book Chapter (23) 23
Magazine Article (18) 18
Book / eBook (6) 6
Conference Proceeding (3) 3
Publication (2) 2
Book Review (1) 1
Newsletter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5333) 5333
male (3835) 3835
animals (3563) 3563
female (2767) 2767
gamma-aminobutyric acid - therapeutic use (2744) 2744
neurosciences (2061) 2061
gamma-aminobutyric acid - metabolism (1768) 1768
adult (1753) 1753
pharmacology & pharmacy (1714) 1714
gaba (1709) 1709
rats (1707) 1707
gabapentin (1703) 1703
middle aged (1614) 1614
gamma-aminobutyric acid - analogs & derivatives (1543) 1543
clinical neurology (1484) 1484
anticonvulsants - therapeutic use (1436) 1436
cyclohexanecarboxylic acids - therapeutic use (1407) 1407
amines - therapeutic use (1406) 1406
gamma-aminobutyric acid (1329) 1329
analgesics - therapeutic use (1195) 1195
gamma-aminobutyric-acid (1140) 1140
pregabalin (1043) 1043
treatment outcome (1022) 1022
psychiatry (1012) 1012
mice (1010) 1010
aged (926) 926
amines (867) 867
cyclohexanecarboxylic acids (859) 859
dose-response relationship, drug (831) 831
double-blind (829) 829
gamma-aminobutyric acid - pharmacology (803) 803
epilepsy (774) 774
brain (755) 755
acetates - therapeutic use (748) 748
disease models, animal (675) 675
rats, sprague-dawley (670) 670
pain (657) 657
neurons (652) 652
gamma-aminobutyric acid - adverse effects (625) 625
glutamate (623) 623
adolescent (611) 611
neurology (591) 591
neuropathic pain (578) 578
gamma-aminobutyric acid - administration & dosage (572) 572
double-blind method (564) 564
epilepsy - drug therapy (562) 562
gamma-aminobutyric acid - physiology (560) 560
care and treatment (530) 530
analysis (529) 529
brain - metabolism (503) 503
drug therapy, combination (469) 469
nervous system (438) 438
research (438) 438
glutamic acid - metabolism (436) 436
rats, wistar (433) 433
time factors (433) 433
seizures (425) 425
pain - drug therapy (416) 416
neuralgia - drug therapy (407) 407
anticonvulsants - pharmacology (406) 406
anticonvulsants - adverse effects (405) 405
pain measurement (403) 403
vigabatrin (382) 382
young adult (379) 379
efficacy (378) 378
medicine, general & internal (377) 377
anesthesiology (376) 376
γ-aminobutyric acid (375) 375
child (371) 371
brain - drug effects (367) 367
neurons - drug effects (365) 365
drug therapy (356) 356
anticonvulsants (354) 354
rodents (346) 346
biochemistry & molecular biology (331) 331
antiepileptic drugs (321) 321
rat (320) 320
neurons - metabolism (315) 315
receptors (310) 310
anxiety (301) 301
physiological aspects (299) 299
amines - administration & dosage (298) 298
cyclohexanecarboxylic acids - administration & dosage (298) 298
drugs (290) 290
dopamine (285) 285
medicine & public health (282) 282
postherpetic neuralgia (282) 282
analgesics - administration & dosage (280) 280
biomedicine (279) 279
receptors, gaba-a - metabolism (279) 279
schizophrenia (277) 277
synaptic transmission - drug effects (276) 276
placebo-controlled trial (274) 274
management (271) 271
pharmacology (270) 270
inhibition (266) 266
hippocampus (263) 263
neurotransmitters (263) 263
randomized controlled trials as topic (260) 260
amines - adverse effects (259) 259
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7748) 7748
Russian (205) 205
Japanese (103) 103
German (93) 93
Spanish (87) 87
French (74) 74
Italian (24) 24
Chinese (21) 21
Polish (20) 20
Portuguese (14) 14
Hungarian (8) 8
Dutch (7) 7
Danish (6) 6
Norwegian (6) 6
Turkish (6) 6
Finnish (5) 5
Swedish (5) 5
Hebrew (3) 3
Romanian (2) 2
Ukrainian (2) 2
Czech (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2012, Volume 2020, Issue 7, p. CD008943
Background Pharmacotherapy remains an important modality for the treatment of neuropathic pain. However, as monotherapy current drugs are associated with... 
gamma-Aminobutyric Acid | Nortriptyline | Amines | Chronic non-cancer pain | Gabapentin | Morphine | Phenylurea Compounds | Pregabalin | Pain & anaesthesia | 2019 3. Chronic pain | 2019 3.1 Neuropathic pain | Analgesics | Acetaminophen | Antidepressive Agents, Tricyclic | Thioctic Acid | Tramadol | Benzodiazepinones | Cyclohexanecarboxylic Acids | N-Methylaspartate | Neuralgia | Pharmacological therapies | Drug Therapy, Combination | Medicine General & Introductory Medical Sciences | MEDICINE, GENERAL & INTERNAL | POSTHERPETIC NEURALGIA | DIABETIC PERIPHERAL NEUROPATHY | SPINAL-CORD-INJURY | CANCER PAIN | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | DOUBLE-BLIND CROSSOVER | LIDOCAINE MEDICATED PLASTER | CHRONIC NONCANCER PAIN | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Humans | Phenylurea Compounds - therapeutic use | N-Methylaspartate - antagonists & inhibitors | Neuralgia - drug therapy | Nortriptyline - therapeutic use | Tramadol - therapeutic use | Drug Therapy, Combination - methods | Antidepressive Agents, Tricyclic - therapeutic use | Amines - therapeutic use | Adult | gamma-Aminobutyric Acid - therapeutic use | Acetaminophen - therapeutic use | gamma-Aminobutyric Acid - analogs & derivatives | Benzodiazepinones - therapeutic use | Morphine - therapeutic use | Thioctic Acid - therapeutic use
Journal Article
Cochrane library, ISSN 1469-493X, 2015, Volume 2020, Issue 9, p. CD007887
Background This is an updated version of the original Cochrane review published in Issue 8, 2011, on 'Drug therapy for treating post‐dural puncture headache'.... 
Post-anaesthetic unit/intensive care unit | Amines | Blood Patch, Epidural | Gabapentin | Sumatriptan | Post-operative pain | Peri-anaesthetic/peri-operative care | Hydrocortisone | 2019 1.2 Not postoperative pain | Analgesics | Child health | Adrenocorticotropic Hormone | Headache & migraine | Caffeine | gamma-Aminobutyric Acid | Post-Dural Puncture Headache | Spinal Puncture | Treatment Outcome | Pain & anaesthesia | Management | 2019 1. Acute pain | Randomized Controlled Trials as Topic | Neurology | Drugs in anaesthesia & intensive care | Other drugs | Cyclohexanecarboxylic Acids | Pain Measurement | Medicine General & Introductory Medical Sciences | Theophylline | ACCIDENTAL DURAL PUNCTURE | Humans | OBSERVER-BLIND | POSTSPINAL HEADACHE | Amines [therapeutic use] | Post-Dural Puncture Headache [drug therapy] | Male | Sumatriptan [therapeutic use] | gamma-Aminobutyric Acid [therapeutic use] | Adrenocorticotropic Hormone [therapeutic use] | EPIDURAL BLOOD PATCH | MEDICINE, GENERAL & INTERNAL | PAIN SCORE | Female | Caffeine [therapeutic use] | Cyclohexanecarboxylic Acids [therapeutic use] | Analgesics [therapeutic use] | Spinal Puncture [adverse effects] | VISUAL ANALOG SCALE | LUMBAR-PUNCTURE | Pain Measurement [methods] | SPINAL-ANESTHESIA | Theophylline [therapeutic use] | DOUBLE-BLIND | CLINICALLY SIGNIFICANT DIFFERENCE | Hydrocortisone [therapeutic use] | Theophylline - therapeutic use | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Post-Dural Puncture Headache - drug therapy | Middle Aged | Sumatriptan - therapeutic use | Hydrocortisone - therapeutic use | Spinal Puncture - adverse effects | Pain Measurement - methods | Caffeine - therapeutic use | Blood Patch, Epidural - methods | Amines - therapeutic use | Adult | gamma-Aminobutyric Acid - therapeutic use
Journal Article
Cochrane library, ISSN 1465-1858, 2013, Volume 2017, Issue 6, p. CD008307
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD009622
Background Gamma aminobutyric acid (GABA) receptor agonists have been shown to have a neuroprotectant effect in reducing infarct size and improving functional outcome in animal models of cerebrovascular disease... 
gamma‐Aminobutyric Acid | Neuroprotective Agents | Neuroprotection | Acute Disease | Chlormethiazole | Stroke | Rhinitis | GABA Agonists | Haemorrhagic stroke | Disorders of Excessive Somnolence | Randomized Controlled Trials as Topic | Neurology | Treatment | ISCHAEMIC/UNSPECIFIED STROKE, TRANSIENT ISCHAEMIC ATTACK | Medical therapy | Heart & circulation | Medicine General & Introductory Medical Sciences | Ischemic stroke/TIA: treatment | Diazepam | Rhinitis [chemically induced] | HYPOTHERMIA | BACLOFEN | RAT | Humans | Disorders of Excessive Somnolence [chemically induced] | Neuroprotective Agents [adverse effects; therapeutic use] | Stroke [drug therapy; mortality] | FLOW | CLOMETHIAZOLE | TRIAL | MEDICINE, GENERAL & INTERNAL | Diazepam [therapeutic use] | Chlormethiazole [adverse effects; therapeutic use] | TRANSIENT | NXY-059 | BRAIN | CHLORMETHIAZOLE | GABA Agonists [adverse effects; therapeutic use] | Neuroprotective Agents - therapeutic use | Disorders of Excessive Somnolence - chemically induced | Diazepam - adverse effects | GABA Agonists - adverse effects | Stroke - drug therapy | GABA Agonists - therapeutic use | Rhinitis - chemically induced | Chlormethiazole - adverse effects | gamma-Aminobutyric Acid - therapeutic use | Diazepam - therapeutic use | Neuroprotective Agents - adverse effects | Stroke - mortality | Chlormethiazole - therapeutic use
Journal Article
American Family Physician, ISSN 0002-838X, 2016, Volume 94, Issue 3, pp. 227 - 234
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2016, Volume 2016, Issue 11, p. CD010690
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2010, Volume 85, Issue 3, pp. S3 - S14
Journal Article